Showing results (191-200 of 2,881) with videos related to
Sort By:
Pageof 289
Expert Opinion on Emerging Drugs|March 17, 2023
A review of emerging factor XI inhibitorsSandra Elsheikh, Nicola Tidbury, Gregory Y H LipJournal of Thrombosis and Thrombolysis|May 25, 2025
Mon4 as a novel monocyte subset with distinct profile and predictor of poor outcomes in individuals with myocardial infarctionMaxime Boidin, Gregory Y H Lip, Eduard ShantsilaThrombosis Research|June 24, 2003
Fibrinolytic function and atrial fibrillationFrancisco Marín, Vanessa Roldán, Gregory Y H LipKardiologia Polska|May 25, 2019
Revisiting the risks of incident atrial fibrillation: a narrative review. Part 2Gaurav Panchal, Maria Mahmood, Gregory Y H LipProgress in Cardiovascular Diseases|January 1, 2018
Quantifying Time in Atrial Fibrillation and the Need for AnticoagulationKazuo Miyazawa, Daniele Pastori, Gregory Y H LipDrugs of Today (Barcelona, Spain : 1998)|March 24, 2007
RivaroxabanPuneet Kakar, Timothy Watson, Gregory Y H LipThe American Journal of Cardiology|May 29, 2004
Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project)Dwayne S G Conway, Gregory Y H LipInternal and Emergency Medicine|June 14, 2011
Peripheral artery disease and atrial fibrillation: a potentially dangerous combinationFrancesco Violi, Gregory Y H Lip, Stefania BasiliKardiologia Polska|April 27, 2019
Revisiting the risks of incident atrial fibrillation: a narrative review. Part 1Gaurav Panchal, Maria Mahmood, Gregory Y H LipCardiology Clinics|April 25, 2022
Atrial Fibrillation in Heart Failure: Focus on Antithrombotic ManagementMohammed Obeidat, Malcolm Burgess, Gregory Y H LipPageof 289